Sensus Healthcare sells SRT system to Providence Swedish Hospital

Sensus Healthcare announces it has shipped an SRT system to Providence Swedish Hospital in Seattle. This sale represents the Company’s latest success in generating interest in superficial radiotherapy, SRT, from community hospital oncology departments. Joe Sardano, chairman and chief executive officer of Sensus Healthcare, said, “Providence Swedish Hospital is a leader in Seattle and the Puget Sound area, and we are delighted their radiation oncology department has recognized the benefits of SRT for treating non-melanoma skin cancer and keloids. We have been working diligently to address the hospital sales opportunity and are receiving a growing number of inquiries from hospitals around the country as they consider making non-invasive skin cancer treatments available on an outpatient basis. Our SRT systems offer an ideal non-surgical, painless and cosmetically appealing option while also helping hospitals to improve resource utilization.”